Phase 1/2 Trial Of Lenalidomide In Combination With Cyclophosphamide and Prednisone (REP) In Patients With Lenalidomide-Refractory Multiple Myeloma (REPEAT-study)
Author(s):
Nijhof, I.S.; Zweegman, S.; Levin, M.D.; Koene, H.R.; Beeker, A.; Bloem, A.C.; Bos, G.M.J.; Faber, L.M.; Klein, S.K.; Kruijf, E.J.F.M. de; Spek, E. van der; Wittebol, S.; Velzen, J.F. van; Kessel, B. van; Mutis, T.; Sonneveld, P.; Lokhorst, H.; Donk, N.W.C.J. van de
